SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-316554
Filing Date
2019-12-18
Accepted
2019-12-17 21:32:33
Documents
6
Period of Report
2019-12-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d852426d8k.htm 8-K 20511
2 EX-1.1 d852426dex11.htm EX-1.1 221802
3 EX-5.1 d852426dex51.htm EX-5.1 6422
4 EX-99.1 d852426dex991.htm EX-99.1 8046
5 GRAPHIC g852426g1218032108938.jpg GRAPHIC 2943
6 GRAPHIC g852426pagenew.jpg GRAPHIC 2254
  Complete submission text file 0001193125-19-316554.txt   265451
Mailing Address 3611 VALLEY CENTER DRIVE SUITE 500 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTER DRIVE SUITE 500 SAN DIEGO CA 92130 858-792-6300
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-50484 | Film No.: 191291171
SIC: 2834 Pharmaceutical Preparations